Target intelligence / Profile preview

L-type amino acid transporter and Sodium-dependent neutral amino acid transporter system B(0) (LAT/B0AT)

Target
LAT/B0AT
Molecular classification
Transporter, Solute carrier family
01

Overview

The L-type amino acid transporters (primarily LAT1/SLC7A5) and the Na+-dependent system B0 (primarily B0AT1/SLC6A19) are critical solute carriers responsible for the transport of neutral amino acids across cellular membranes. LAT1 is a sodium-independent exchanger that is frequently overexpressed in various cancers to support the high metabolic demands of proliferating cells by importing essential amino acids like leucine, which in turn activates the mTORC1 pathway. In contrast, B0AT1 is a sodium-dependent symporter mainly expressed in the kidney and intestine, playing a vital role in the systemic absorption and reabsorption of neutral amino acids. While both systems are essential for nutrient homeostasis, LAT1 is a prominent oncology target for inhibiting tumor growth, whereas B0AT1 is investigated in the context of metabolic diseases such as diabetes and obesity. This combined entry is considered 'incorrect' as a single canonical target because it merges two distinct transport systems with different driving forces and physiological roles.

Other names
System L amino acid transportersSystem B(0) amino acid transportersSLC7A5SLC6A19Large neutral amino acids transporterB(0)AT1
02

Mechanism of action

Inhibition of amino acid uptake to deplete essential nutrients in cancer cells or modulation of systemic amino acid homeostasis.

03

Biological functions

Amino acid transportProtein synthesisCell growth regulationmTORC1 activationNutrient sensing
04

Disease associations

CancerHartnup disorderMetabolic syndromeType 2 diabetesNeurological disorders
05

Safety considerations

Disruption of blood-brain barrier amino acid transportPotential for malabsorption syndromesInterference with endogenous neurotransmitter precursor transport
06

Interacting drugs

JPH203

4 more in the full profile.

07

Biomarkers

LAT1 expression (IHC)SLC6A19 genetic variantsPlasma neutral amino acid levels

Beyond the preview

Go deeper on L-type amino acid transporter and Sodium-dependent neutral amino acid transporter system B(0) (LAT/B0AT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-type amino acid transporter and Sodium-dependent neutral amino acid transporter system B(0) (LAT/B0AT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call